Form 4: Twist Bioscience CFO Adam Laponis Sells Shares to Cover Tax Obligations

Adam Laponis, CFO of Twist Bioscience, sold 856 shares of common stock on October 9, 2024, to cover tax withholding obligations related to vesting restricted stock units.

Summary

• On October 9, 2024, Adam Laponis, the Chief Financial Officer of Twist Bioscience Corp, sold 856 shares of the company's common stock.
• The sale was executed at a price of $41.812 per share.
• The transaction was conducted to cover tax withholding obligations associated with the vesting of restricted stock units.
• Following the transaction, Laponis directly owns 73,397 shares of Twist Bioscience Corp.
• The reported transaction does not represent discretionary trades by the reporting person.

Sentiment

Score: 6

Explanation: The sentiment is neutral as the transaction is a routine sale to cover tax obligations and doesn't reflect a change in the executive's confidence in the company.

Industry Context

Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives and do not necessarily indicate a negative outlook on the company's future.

Stakeholder Impact

• The sale of shares by the CFO could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.

Key Dates